VivoSeq
Other

Opioid Analgesia

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Opioid Analgesia is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

7/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

14

clinical trials

Completed9 · 64%
Active, not recruiting2 · 14%
Withdrawn1 · 7%
Unknown status1 · 7%
Recruiting1 · 7%

Trial Activity

14 trials

Nonopioid Analgesia After Labral Surgery
Recruiting·HHenry Ford Health System·Phase 2/3·NCT03825809·100 enrolled
μ-opioid Receptor Polymorphism and Opioid Analgesia
Completed··N/A·NCT02099877·250 enrolled
Opioid Analgesia for MAB
Completed·OOregon Health and Science University·Phase 4·NCT03139240·172 enrolled
Nonopioid Analgesia After Rotator Cuff Repair
Completed·HHenry Ford Health System·Phase 2·NCT03818919·70 enrolled
Assessment of Opioid Analgesia in Sickle Cell
Withdrawn··Phase 4·NCT00513864

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)